Etiology of urogenital discharges and their antibiograms in HIV/AIDS positive patients at Bwizibwera Health Centre IV: Mbarara District- Uganda

Similar documents
STIs- REVISION. Prof A A Hoosen

REPRODUCTIVE TRACT INFECTIONS

Refocussing on STI management to impact HIV prevention

Sexually Transmitted Infections in the Adolescent Population. Abraham Lichtmacher MD FACOG Chief of Women s Services Lovelace Health System

SYNDROMIC CASE MANAGEMENT OF RTIs Advantages, Limitations, Optimization

Office and Laboratory Management of Genital Specimens

GUIDELINES FOR THE MANAGEMENT OF SEXUALLY TRANSMITTED INFECTIONS

Antibiotic Resistance Pattern of Blood and CSF Culture Isolates At NHLS Academic Laboratories (2005)

Microbial Diseases of the Urinary and Reproductive Systems

ENG MYCO WELL D- ONE REV. 1.UN 29/09/2016 REF. MS01283 REF. MS01321 (COMPLETE KIT)

Chlamydia Rapid Screen Test (RAP-2858) RUO in the USA. Revised 28 Jul 2006

Sexually Transmi/ed Diseases

STI Treatment Guidelines. Teodora Wi. Training Course in Sexual and Reproductive Health Research

6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.?

URINARY TRACT INFECTIONS IN DIABETIC PATIENTS ATTENDING OUTPATIENT DEPARTMENTS AT KASTURBA MEDICAL COLLEGE TEACHING HOSPITAL, MANIPAL, INDIA

CHAPTER 26 - Microbial Diseases of the Urinary and Reproductive System

URINARY TRACT INFECTIONS 3 rd Y Med Students. Prof. Dr. Asem Shehabi Faculty of Medicine, University of Jordan

WHAT DO U KNOW ABOUT STIS?

Practice Steps for Implementation of Guidelines Recommendations The guideline recommendations are shown schematically -

CHAPTER 1: SEXUALLY TRANSMITTED AND BLOODBORNE INFECTIONS

How is it transferred?

Susceptibility of Pathogens Associated with Pelvic Inflammatory Disease to Antimicrobial Agents in Western U.P. India

Timby/Smith: Introductory Medical-Surgical Nursing, 9/e

A.F. GENITAL SYSTEM. ITEMS NECESSARY BUT NOT INCLUDED IN THE KIT A.F. GENITAL SYSTEM Reagent (ref ) Mycoplasma Transport Broth (ref.

6. Gonococcal antimicrobial susceptibility

Pelvic Inflammatory Disease (PID) Max Brinsmead PhD FRANZCOG July 2011

320 MBIO Microbial Diagnosis. Aljawharah F. Alabbad Noorah A. Alkubaisi 2017

Index. Infect Dis Clin N Am 19 (2005) Note: Page numbers of article titles are in boldface type.

Sexually transmitted infections

OAML Guideline on the Investigation of Genital Tract Infections November, 2015

Buve, A., H. A. Weiss, et al. (2001). The epidemiology of trichomoniasis in women in four African cities. Aids 15 Suppl 4: S89-96.

URINARY TRACT INFECTIONS 3 rd Y Med Students. Prof. Dr. Asem Shehabi Faculty of Medicine, University of Jordan

Microbiology - Problem Drill 22: Microbial Infections of Urinary & Reproductive Systems

SYNDROMIC CASE MANAGEMENT OF STD

Asymptomatic Bacteriuria In Female Students Population Of A Nigerian University

5/1/2017. Sexually Transmitted Diseases Burning Questions

Changing Trends of STIs/HIV/AIDS: An Overview

7/13/2018. NEW TESTS - Please update your EMR catalog with those appropriate to your practice

Prevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital

Sexually Transmitted Diseases. Summary of CDC Treatment Guidelines

Contributors: Reviewers: Graphic Designer:

Nothing to disclose.

Sexually Transmitted Diseases This publication was made possible by Grant Number TP1AH from the Department of Health and Human Services,

-Almost one third of cases admitted to medical centers are related to urinary tract infection

The objectives of this presentation are; to increase awareness of the issue of antimicrobial resistant gonorrhea, and to inform primary care and

Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management. William M. Geisler M.D., M.P.H. University of Alabama at Birmingham

Sexually Transmitted Infections. Naluce Manuela Morris, MPH, CHES

Sexually Transmitted Infection surveillance in Northern Ireland An analysis of data for the calendar year 2011

LABORATORY DIAGNOSIS SEXUALLY TRANSMITTED DISEASES

Vaginitis. Antibiotics Changes in hormone levels due to pregnancy, breastfeeding, or menopause Douching Spermicides Sexual intercourse Infection

STI Indicators by STI

Chapter 25 Notes Lesson 1

Trends in STDs among Young People in New York State

Strategies to achieve STI control in South Africa Prof Remco Peters

Urinary tract infections Dr. Hala Al Daghistani

IP Lab Webinar 8/23/2012

Answers to those burning questions -

Sexually Transmitted Infections

STD UPDATE 2017 FSACOFP CONVENTION

Investigation and Management of Vaginal Discharge in Adult Women

Looking at NY: Our rate of chlamydia is higher than the US as a whole; we rank 13th among all states.

N ational STI M icrobiological Surveillance Programme David A. Lewis FRCP(UK) PhD

Women s Sexual Health: STI and HIV Screening. Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins

Pelvic Inflammatory Disease

Communicable Diseases

Sep Oct Nov Dec Total

CHLAMYDIA/GC AMPLIFIED RNA ASSAY

toe... Chlamydia - CDC Fact Sheet Appendix K - Part 2

The prevalence of microbial isolates associated with infertility in men attending clinic at OAUTHC, Ile-Ife

Sexually Transmitted Infections. Kim Dawson October 2010

BACTERIOLOGY PROGRAMME AND PLAN OF TEACHING 3 rd Semester (academic year )

STIs: Practical Aspects of Management

Biology 3201 Unit 2 Reproduction: Sexually Transmitted Infections (STD s/sti s)

St. Joseph's Journal of Humanities and Science ISSN:

½ of all new infections are among people aged although this age group represents <25% of the sexually experienced population.

Urethritis in women attending an STD clinic

17a. Sexually Transmitted Diseases and AIDS. BIOLOGY OF HUMANS Concepts, Applications, and Issues. Judith Goodenough Betty McGuire

Nigerian Journal of Experimental and Applied Biology

Professor Jonathan Ross

Urinary Tract Infections Among Female Students Of The University Of Agriculture, Makurdi, Benue State, Nigeria

COMMUNICABLE DISEASE REPORT

Guidelines for the Laboratory Detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Treponema pallidum Testing

Treatment resistant STIs relevant to MSM

Sexually Transmitted Infections Epidemiology

Julie Nelson RNC/WHNP-BC Epidemiology NURS 6313

Microbiology products. Liofilchem Chromatic

TRICHOMONAS VAGINALIS

Yaarub Ibraheem Salih Dept. of Community Medicine, College of Medicine, Tikrit University.

Complex Vaginitis Cases: Applying New Diagnostic Methods to Enhance Patient Outcomes ReachMD Page 1 of 5

Sexually Transmitted Infection surveillance in Northern Ireland An analysis of data for the calendar year 2016

Sinan B. Issa, Dept. of Microbiology, College of Medicine, Tikrit University

Sexually Transmitted Infection Treatment and HIV Prevention

CDC Laboratory Update

Prevalence of human papillomavirus and bacteria as sexually transmitted infections in symptomatic and asymptomatic women

New diagnostic tests for sexually transmitted infections. Jens Van Praet 30/11/2018

In Canada and around the world, the trend is clear: sexually transmitted infections (STIs) are on the rise.

Sexually Transmissible Infections (STI) and Blood-borne Viruses (BBV) A guide for health promotion workers

Bacterial Isolation from Hospitalized Diabetic Patients Infected with Urinary Tract Infection in Ibrahim Malik Hospital

Chain of Infection Agent Mode of transmission Contact (direct, indirect, droplet spread) Airborne Common-vehicle spread Host

Transcription:

Issues in Biological Sciences and Pharmaceutical Research Vol. 2(8),pp.075-080, September 2014 Available online at http://www.journalissues.org/ibspr/ http://dx.doi.org/10.15739/ibspr.001 2014 Journal Issues ISSN 2350-1588 Original Research Article Etiology of urogenital discharges and their antibiograms in HIV/AIDS positive patients at Bwizibwera Health Centre IV: Mbarara District- Uganda Accepted 22 August, 2014 Gidudu Samuel Medical Laboratory Science Department, Faculty of Medicine, Mbarara University of Science and Technology, Uganda Author samuelgidudu_mlso@yahoo.com Tel: +256-704-777-931 The study aimed at establishing the etiology of urogenital discharges and their antibiograms in HIV/AIDS positive patients attending the HIV/AIDS clinic at Bwizibwera health center IV in Mbarara district, Uganda. This was a non- interventional descriptive laboratory based study. Forty (40) HIV positive patients with a urogenital discharge, read, understood and signed the consent forms were enrolled into the study. Of these, (47.5%, 19/40) were males and (52.5%, 21/40) were females. Out of eighty (80) urogenital swabs obtained, 40 of them were cultured on various culture media while the other 40 were used for serological tests. Chloramphenicol, penicillin, ceftriaxone, gentamycin, erythromycin and tetracycline antibiotics were used for sensitivity.a total of nine microorganisms were isolated [N. Gonorrhoeae (37.1%, 13/35), Staphylococcus aureus (22.9%, 8/35), Candida albicans (14.3%, 5/35),Enterococcus faecalis (8.6%, 3/35), Klebsiella pneumonia (5.7%, 2/35), non C. albicans species (2.9%, 1/35), Escherichia coli (2.9%, 1/35), Pseudomonas stuttzeri (2.9%, 1/35) and Pseudomonas aeruginosa (2.9%, 1/35)], serologically, all participants tested negative for Chlamydia.Majority of the isolates were sensitive to chloramphenicol (85.2%, 23/27), gentamycin (66.7%, 18/27), erythromycin (68.2%, 15/22) and lastly ceftriaxone (51.9%, 14/27), but also resistant to penicillin (59.1%, 13/22) and tetracycline (51.9%, 14/27).The study revealed Gonorrhoea (37.1%) as the highly prevalent urogenital infection and the least was candidiasis. Most of the isolates proved sensitive to chloramphenicol, gentamycin, erythromycin and ceftriaxone, as applied antibiotics in this study and resistant to only two of them i.e. penicillin and tetracycline. Key words: HIV/AIDS positive patients, urogenital discharges, sexually transmitted diseases INTRODUCTION Human immunodeficiency virus (HIV) positive patients are increasingly getting infected with other urogenital infections (Hansjakob, 2013). While HIV infects all body organs in order to manifest with different symptoms and complication, the genital urinary system is also affected (Azore, 2005). Diseases transmitted by the direct sexual contact usually affect the reproductive system and urinary system; but can also spread to other organs and body systems (sexually transmitted disease (STD), 2012). Yeast infections are also commonly diagnosed in the urogenital discharge in both men and women (STD, 2012). Studies have shown that HIV positive individuals having other urogenital infections are more likely to be in a critical state than those without the urogenital infections because of their already compromised immunity (Centre for Disease Control, (CDC), 2010). Also, consequences of urogenital

Issues Biol. Sci. Pharm. Res. 076 infections amongst HIV positive clients/ patients can be grave, resulting in conditions like infertility, ectopic pregnancy, cancer, and neonatal infections (Charanchi, Kudi, & Tahir, 2012). Certain behaviors like having more than one sexual partner and irregular usage of condoms may lead to contracting these other urogenital infections (Workowski & Berman, 2010). In the study done on the etiology and STI/HIV coinfections among patients with urethral and vaginal discharge syndromes in South Africa, it was found out that the prevalence of the male urethral discharge was at 92% while the vaginal discharge was at 85% (Mhlongo et al., 2010). Neisseria gonorrhoeae was found to be at 85% in Cape Town and 71% in Johannesburg, while Chlamydia trachomatis was found to be the second highest with 13% in Cape Town and 24% in Johannesburg (Mhlongo et al., 2010). In addition, the researchers also noted that, bacterial vaginosis was most common standing at 46 % in Cape Town and 36% in Johannesburg (Mhlongo et al., 2010). Trichomoniasis that was at 19% in Cape Town and 34 % in Johannesburg and syphilis that was at 4% was also documented (Mhlongo et al., 2010). In the study conducted in Gombe on the antibiotic susceptibility of urogenital discharge causative agents in HIV positive patients, six opportunistic bacterial species were isolated of which Staphylococcus aureus had the highest frequency of 9 (30.0%) while Enterococcus faecalis had the lowest as 1(3.3%) (Charanchi et al., 2012).The most active drug against S. aureus observed was augmentin (71.4%) (Charanchi et al., 2012). In addition to the above isolates (Staphylococcus aureus and Enterococcus faecalis), two exogenous bacterial species were isolated; Neisseria gonorrhoea which was resistant to tetracycline and Haemophilus species which was sensitive to all antibiotics apart from co-trimoxazole and fusidin (Charanchi et al., 2012). According to the study conducted in south west Ethiopia on the rates of susceptibility of urogenital discharge causatives to commonly used antibiotics, it was found out that, all the isolates were sensitive to chloramphenicol (100 %, 27/27) (Agersew et al., 2012). Most of Gram negative isolates were sensitive to ceftriaxone, ciprofloxacin, norfloxacin, gentamycin, amoxicillin-clavulanic acid, cotrimoxazole and tetracycline while Gram positive isolates were sensitive to ceftriaxone, gentamycin and amoxicillinclavulanic acid (Agersew et al., 2012). It was also found out that, all the Gram negative isolates were resistance to ampicillin, and amoxacillin and that majority of Gram positive isolates were resistant to most of the antibiotics tested than the Gram negative isolates (Agersew et al., 2012). According to the study conducted in Abakaliki, it was found out that, the antimicrobials used that showed the greatest sensitivity to the isolated organisms (Klebsiella species, S. aureus, Pseudomonas species, Streptococcus species, E. coli, Proteus species and Citrobacter species) were gentamycin (45.5%), ceftriaxone (44.5%), and ciprofloxacin (32.7%) (Muoneke & Ibekwe, 2012). According to the study done in Uganda on the vulnerability and risk factors of STDs and HIV amongst the adolescents in Kampala, Uganda, the prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis and Treponema pallidum was recorded to be 4.5%, 9.0%, 8.0%, and 4.0% respectively for female, and 4.7%, 5.7%, 0.0%, and 2.8% respectively for males (Rassjo, Mirembe & Darj, 2006). The study also revealed that 20.6% of the female and 13.2% of the male had at least one STD (Rassjo et al., 2006). At Bwizibwera health center IV which was the study centre of this research project, the causative agents of urogenital discharges amongst these patients was not established and yet these HIV positive patients were constantly presenting with urogenital discharges with the rate of more than 4 cases per week (Kibombo Dan 2012, pers. comm., 31st February). Since a urogenital discharge is one of the commonest symptoms of urogenital infections, it indicates that, there might be a possibility of these patients having other urogenital infections in addition to HIV and/or there is an increase in HIV transmission within the community (CDC, 2010). This projected that the problem would therefore lead to an increase in HIV amongst the people in the Bwizibwera community and also since the immunity of these patients is already compromised, contraction of any other STDs would cause them to die (CDC, 2010). The research was therefore intended to establish the actual causative microorganisms of the urogenital discharges amongst the HIV positive patients attending the HIV clinic at Bwizibwera health center and also establish the antibiograms of the causative microorganisms where possible. The specific objectives included identifying the microorganisms causing urogenital discharges in HIV positive patients using both serological and biochemical tests and determining the susceptibility pattern of the isolates to commonly used antibiotics. MATERIALS AND METHODS This was a non- interventional descriptive laboratory based study conducted at Bwizibwera health centre IV, Mbarara district, western Uganda which is about 25 km from Mbarara town, Ibanda road. Whose sample size was 40 that obtained from the standard formula shown below, N = Z 2 P Q D 2 (Lwanga and Yook, 1986) Where N is the sample size in the study, Z is the zero score (1.96) equivalent to 95% confidence interval, P is the estimated prevalence = 0.13, Q is 1-p-0.05 where 0.05is the significance level, while D is the magnitude of the confidence interval which is 0.1% Solution: Therefore,

Gidudu 077 Table 1: Number of specimens: 35 Microorganisms Frequency Percent Staphylococcus aureus 8 22.9 Candida albicans 5 14.3 Non C.albicans spp 1 2.9 Neisseria gonorrheae 13 37.1 Pseudomonas 1 2.9 aeruginosa E. coli 1 2.9 Klebsciella pneumoniae 2 5.7 Pseudomonas stutzeri 1 2.9 Enterococcus faecails 3 8.6 Total 35 100.0 N is 40.95: implying that the sample size of the study was 40. Forty (40) HIV positive patients with a urogenital discharge were enrolled into the study through signing the study consent forms. Of these, (47.5%, 19/40) were males and (52.5%, 21/40) were females. Out of eighty (80) urogenital swabs obtained, 40 of them were cultured on various culture media while the other 40 were used for serological tests. For each participant, a pair of new sterile hand gloves was worn; cotton wool moistened in sterile normal saline was used to clean around the genital opening. For the urethral swab sample, the urethra was gently massaged from above downwards until sufficient amount of discharge was seen to be flowing which was then collected directly onto a new sterile swab stick. For the endocervical swab sample, the cervix was cleansed using a sterile swab moistened in sterile normal saline. With the use of a sterile vaginal speculum, another sterile swab stick was then inserted down to the endocervical canal and gently rotated so as to obtain the specimen. All samples were carefully and properly labeled and immediately taken to the Mbarara university microbiology laboratory located on second floor, faculty of medicine building, Mbarara University for the period between the months of January to April, 2013 for processing and examination. In the lab, the urogenital swab was subjected to culture, Gram stain, wet preparation and serology technique. Pure isolated organisms were subjected to antibiotic susceptibility testing using Kirby-Bauer disc diffusion method and the sensitivity pattern of the antibiotics was interpreted following the clinical and laboratory standard institute guidelines. Standard reference strains of E. coli ATCC (American Type Culture Collection) 2592 and S.aureus 25923 were used as controls with E. coli representing the Gram negatives while S.aureus representing the Gram positives. The research findings were analyzed using a Statistical Package for the Social Sciences (SPSS) version 20 and presented in form of charts and tables. Before the researcher started on this research, permission was sought from research participants, Faculty Research Ethics Committee (FREC), the site manager of Makerere Joint AIDS Programme (MJAP) at Bwizibwera heath center IV and the project manager of MJAP, Mbarara branch. A pilot study was conducted to test the data collecting tool. Codes instead of names were used as sample identification names. Results obtained were availed to only the clinicians, who helped in the proper management and treatment of the participants. The raw data was kept safe in the department of medical laboratory science. RESULTS Microorganisms isolated In this study, 35 culture plates had significant growth while 5 culture plates did not have significant growth. Those with significant growth generated a total of nine isolates, of which Neisseria Gonorrhoeae was the highly prevalent isolate amongst the Gram negatives, Staphylococcus aureus was the highly prevalent isolate amongst the Gram positives while Candida albicans was the highly prevalent isolate amongst the Candida species. Serologically all participants tested negative for the chlamydia test. The isolated organisms are summarized in the Table 1. The male participants had more of Neisseria Gonorrhoeae as compared to their counterparts the female participants as shown in Figure 1. Susceptibility pattern of the isolates In this study, the most active drug against Gram positive organisms particularly S. aureus was gentamycin (27.6%) and most resistant was penicillin (20.8%) while the most active drug against Gram negative organisms particularly N. Gonorrhoeae was erythromycin (41.7%) and most resistant was penicillin (33.3%). The antimicrobial susceptibility pattern of the isolates is summarized in Figure 2. DISCUSSION This study revealed a co-infection amongst the HIV positive participants. Both the exogenous microorganisms and the endogenous microorganisms were isolated adding up to nine (9) isolates in total. These finding were slightly similar to the study conducted by Charanchi et al (2012) who isolated six (6) endogenous microorganisms and two (2) exogenous microorganisms adding up to eight (8) isolates in total. This might have been due to the fact that the participants were already immune compromised (CDC, 2010). This study revealed Neisseria gonorrhoeae as the highly prevalent isolate which was similar to the studies

Issues Biol.Sci. Pharm. Res. 078 Figure 1: Isolated microorganisms amongst female and male research participants Figure 2: Antibiotic sensitivity pattern

Gidudu 079 conducted in South Africa by Mhlongo et al (2010) and that conducted in Uganda by Rassjo et al (2006) who also obtained Neisseria gonorrhoeae as their highest isolate with a prevalence of (85%) and (9%) respectively but contrary to that by Charanchi et al (2012) whose N. gonorrhoeae (6.6%, 2/30) was not the highest. This is probably because it is the most prevalent isolate amongst these research participants. Among the opportunistic bacterial infections isolated in this study, Staphylococcus aureus had the highest percentage prevalence of (22.9%, 8/35), which was close to the study done by Charanchi et al (2012) who also obtained Staphylococcus aureus as their highest opportunistic bacteria at (30%, 9/30). This might have been because Staphylococcus aureus has the ability to, survive in minimal growth requirements, withstand high resistance from environmental factors, colonise and establish infection in almost every site of the body especially those that have reduced immunity (Charanchi et al., 2012). This study was slightly similar to the study conducted in Gombe that also isolated E. coli (23.3%, 7/30), Klebsiella pneumoniae (16.5%, 5/30), Pseudomonas aeruginosa (10%, 3/30), Entrobacter species (6.6%, 2/30), N. Gonorrhoeae (6.6%, 2/30), Hemophillus species (3.3%, 1/30) and Enterococcus faecalis (3.3%, 1/30) (Charanchi et al., 2012). This was contrary to the studies done in South Africa by Mhlongo et al (2010) and in Uganda by Rassjo et al (2006), who both, in addition to Neisseria gonorrhoeae, isolated; Chlamydia trachomatis, Trichomonas vaginalis and Treponema pallidum. This is probably because these research participants do not have these infections (Chlamydia trachomatis, Trichomonas vaginalis and Treponema pallidum). Pseudomonas stuttzeri isolated in this study, is one of those rare isolates obtained from urogenital discharges (Bisharat, Gorlacev & Keness, 2012). Previous literature has it that, when P. stutzeri is isolated from clinical material, it most likely represents colonization in hospitalized patients and uncommonly indicates pathogenicity thus implying that, the clinical significance of this isolated still remains unknown (Bisharat et al., 2012). Cases of P. stutzeri infection concern typically immunocompromised patients with underlying diseases like HIV/AIDS (Bisharat et al., 2012). Majority of the isolates were sensitive to chloramphenicol (86.2%, 25/29), erythromycin (70.8%, 17/24), gentamycin (62.1%, 18/29) and ceftriaxone (55.2%, 16/29), but also resistant to penicillin (54.2%, 13/24) and tetracycline (48.3%, 14/29). The most active drug against Gram positive organisms particularly S.aureus was gentamycin (27.6%) and most resistant was penicillin (20.8%). The most active drug against Gram negative organisms particularly N. gonorrhoeae was erythromycin (41.7%) and most resistant was penicillin (33.3%). This was partly similar to the study by Charanchi et al (2012) who demonstrated that N. gonorrhoeae was resistant to tetracycline. In their study, they used augmentin which was the most active drug against S.aureus and yet in this study, gentamycin was used which also proved to be the most active drug against S.aureus. The 5 culture plates did not have significant growth probably because of the antibiotics taken prior to sample collection. In conclusion, this study revealed N. gonorrhoeae most prevalent isolate in the urogenital tract infections and that most of the isolates proved sensitive to chloramphenicol, gentamycin, erythromycin and ceftriaxone, as applied antibiotics in this study and resistant to only two of them i.e. penicillin and tetracycline. The researcher therefore recommends that hospitals should improve on the way of counseling the HIV positive patients in relation to safe sex practice; a larger sample size be conducted to obtain the prevalence of Neisseria gonorrhoeae and in relation to HIV in the Bwizibwera community; microbiology lab be set up in order to conduct the earlier and effective diagnosis for proper patient management and care; chloramphenicol, gentamycin erythromycin and ceftriaxone, be used to treat Urogenital / Urinary Tract Infections (UTIs) while tetracycline and penicillin be removed from the antibiotic spectrum for treating UTIs due to the development of antibiotic pressure against these two antibiotics. ACKNOWLEDGEMENT Great thanks to God the almighty for having blessed this research study. Great thanks go to my parents (Rt. Rev. Patrick Gidudu and Mrs. Hannah Gidudu), my siblings (Emma, Marion and Janet Gidudu), Dr. Jeanette Meadway, Mr. John Meadway, Mrs. Betty Gabona who supported me all throughout my academics. Many thanks go to all Mbarara university especially Assoc. Prof. Maling Samuel, Assoc. Prof. Apecu Onyuthi Richard, Mr. Muhindo Abraham, Mr. Kibombo Dan, Dr. Dathan Mirembe, Mr. Itebangi Hebert, Mr. Lwanga, Mr. Tumwesigye James, and Mr. Iramiot Stanley Jacob for their dedicated time they put into this work. REFERENCES Agersew A, Feleke M, Yitayal S, Ketema T, Afework K, Belay A, Abebe A (2012). Bacterial profile and drug susceptibility pattern of urinary tract infection in

Issues Biol. Sci. Pharm. Res. 080 pregnant women at University of Gondar Teaching Hospital, Northwest Ethiopia. BMC res. notes, 5 (197): 8-10. Azore E (2005). Causative bacterial microorganisms of urinary tract infection and their antibiogram in HIV/AIDS patients at Mbarara university teaching hospital.mbarara. Dissertation, (1): 1-2. Bisharat N, Gorlacev T, Keness Y (2012). 10-Years Hospital Experience in Pseudomonas stutzeri and Literature review. Open Infec. Dis. J. 6(12): 21-24. Centers for Disease Control and Prevention (2010). Sexually Transmitted Diseases (STDs). Accessed on 4th/June/2013. Available at: www.cdc.gov/std/treatment/2010/hiv.htm. Charanchi S, Kudi A, Tahir F (2012). Antimicrobial sensitivity patterns of urogenital bacterial isolates among HIV positive patients in the federal medical centre in Gombe. Int. J. Infect. Dis.10 (1):1 Hansjakob F (2011). Prevalence of Sexually Transmitted Infections (STIs) in HIV-positive Patients. University Hospital Berne. Accessed on 04/September/2014. Available at: http://clinicaltrials.gov/show/nct00973466. Lwanga SK, Yook T (1986). Calculation of sample size. Belgium: Ceuterick. Mhlongo S, Magooa P, Muller EE, Nel N, Radebe F, Wasserman E, Lewis DA (2010). Etiology and STI/HIV coinfections among patients with urethral and vaginal discharge syndromes in South Africa. American STD Assoc. J. 37(9): 566-570. Muoneke V, Ibekwe R (2012). Childhood Urinary Tract Infection in Abakaliki. Annals Medical Health Sci. Res. II(1): 29-32. Rassjo E, Mirembe F, Darj E (2006). Vulnerability and risk factors for sexually transmitted infections and HIV among adolescents in Kampala, Uganda. 18(7): 710-716. Sexually transmitted disease (2012). Encyclopaedia Britannica, Inc. Accessed on 3 rd / 09/2012. Available at: http://www.britannica.com/ebchecked/topic/537217/s exually-transmitted-disease-std. Workowski KA, Berman S (2010). Sexually Transmitted Diseases Treatment Guidelines. Centers for disease control and prevention. Accessed on 8 th /09/2014. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr591 2a1.htm.